Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

We studied the safety and clinical outcomes of patients treated with umbilical cord blood (UCB)-derived regulatory T cells (Tregs) that expanded in cultures stimulated with K562 cells modified to express the high-affinity Fc receptor (CD64) and CD86, the natural ligand of CD28 (KT64/86). Eleven pati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood
Glavni autori: Brunstein, Claudio G., Miller, Jeffrey S., McKenna, David H., Hippen, Keli L., DeFor, Todd E., Sumstad, Darin, Curtsinger, Julie, Verneris, Michael R., MacMillan, Margaret L., Levine, Bruce L., Riley, James L., June, Carl H., Le, Chap, Weisdorf, Daniel J., McGlave, Philip B., Blazar, Bruce R., Wagner, John E.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2016
Teme:
Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768428/
https://ncbi.nlm.nih.gov/pubmed/26563133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-06-653667
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items